Product Information
BONJESTA ER 20-20 MG TABLET is a brand product labeled by Duchesnay USA, Inc., priced at $11.1145 per EA under NDC 55494012060. Its NADAC has been published 410 times since Sep 19, 2018.
FDA first approved this application on Nov 7, 2016.
The High Outlier badge above means this manufacturer's average price in the doxylamine succinate and pyridoxine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20; 20 mg/1; mg/1
Manufacturer
Duchesnay USA, Inc.NDC
55494012060
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA209661FDA Approved
11/7/2016
On Market Since
2/19/2018
Pharmacological Classes
Price Statistics
The NADAC for BONJESTA ER 20-20 MG TABLET has been published 410 times since Sep 19, 2018, and over the history we have for it it has risen 12.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.1145 per EA |
|---|---|
| All-time high | $11.1951 (Mar 15, 2023) |
| All-time low | $9.8677 (Sep 19, 2018) |
| 52-week high | $11.1248 |
| 52-week low | $11.1112 |
| Median price | $11.1181 |
| Average price | $10.7951 |
| Largest weekly change | +5.0% (Jan 12, 2022) |
| Weeks tracked | 410 |
| Tracking since | Sep 19, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the doxylamine succinate and pyridoxine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BONJESTA ER 20-20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BONJESTA ER 20-20 MG TABLET, manufactured by Duchesnay USA, Inc., is $11.1145 per EA (NDC 55494012060), effective Aug 19, 2026.
How has the price of BONJESTA ER 20-20 MG TABLET changed over time?
Over the history we have for it, the NADAC for BONJESTA ER 20-20 MG TABLET has risen 12.6%. It has been tracked across 410 weekly CMS publications since Sep 19, 2018.
What are the highest and lowest recorded NADAC prices for BONJESTA ER 20-20 MG TABLET?
Since Sep 19, 2018, the NADAC for BONJESTA ER 20-20 MG TABLET has ranged from a low of $9.8677 (Sep 19, 2018) to a high of $11.1951 (Mar 15, 2023), with a median of $11.1181 per EA.
Are there cheaper alternatives to BONJESTA ER 20-20 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of BONJESTA ER 20-20 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BONJESTA ER 20-20 MG TABLET?
BONJESTA ER 20-20 MG TABLET (NDC 55494012060) is labeled by Duchesnay USA, Inc., and CMS classifies it as a brand product.